Evidence map›Paper›PMID 21547610›Full record

Trial reportJournal of general internal medicine2011

Patient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE).

Courtney R Lyles, Andrew J Karter, Bessie A Young, Clarence Spigner, David Grembowski, Dean Schillinger, Nancy Adler

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of general internal medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Stressful life events in electronic health records: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Courtney R LylesDepartment of Health Services, University of Washington School of Public Health, Seattle, WA, USA. crees@u.washington.edu
Andrew J Karter
Bessie A Young
Clarence Spigner
David Grembowski
Dean Schillinger
Nancy Adler

Funding

University of Washington Health Services Research Training ProgramT32HS013853 · AHRQ · UNIVERSITY OF WASHINGTON · PI WEINER, BRYAN J., WILLIAMS, EMILY CATERINA · 2003 to 2024
$6.9M
Ethnic Disparities in Diabetes ComplicationsR01DK065664 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI KARTER, ANDREW JOHN · 2004 to 2008
$3.3M
Educational Disparities in Diabetes ComplicationsR01HD046113 · NICHD · KAISER FOUNDATION RESEARCH INSTITUTE · PI KARTER, ANDREW JOHN · 2003 to 2006
$1.6M
Medication Adherence and Social Disparities in DiabetesR01DK080726 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI KARTER, ANDREW JOHN · 2009 to 2012
$1.5M
AHRQ HHS HS013853AHRQ HHS T32 HS013853NICHD NIH HHS R01 HD046113NICHD NIH HHS R01 HD46113NIDDK NIH HHS R01 DK065664NIDDK NIH HHS R01 DK080726NIDDK NIH HHS R01 DK65664
6 · The paper itself

Abstract

backgroundRacial/ethnic minority patients are more likely to report experiences with discrimination in the healthcare setting, potentially leading to reduced access to appropriate care; however, few studies evaluate reports of discrimination with objectively measured quality of care indicators.

objectiveTo evaluate whether patient-reported racial/ethnic discrimination by healthcare providers was associated with evidence of poorer quality care measured by medication intensification. RESEARCH DESIGN AND

participantsBaseline data from the Diabetes Study of Northern California (DISTANCE), a random, race-stratified sample from the Kaiser Permanente Diabetes Registry from 2005-2006, including both survey and medical record data. MAIN MEASURES: Self-reported healthcare provider discrimination (from survey data) and medication intensification (from electronic prescription records) for poorly controlled diabetes patients (A1c ≥9.0%; systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg; low-density lipoprotein (LDL) ≥130 mg/dl). KEY

resultsOf 10,409 eligible patients, 21% had hyperglycemia, 14% had hyperlipidemia, and 32% had hypertension. Of those with hyperglycemia, 59% had their medications intensified, along with 40% with hyperlipidemia, 33% with hypertension, and 47% in poor control of any risk factor. In adjusted log-binomial GEE models, discrimination was not associated with medication intensification [RR = 0.96 (95% CI: 0.74, 1.24) for hyperglycemia, RR = 1.23 (95% CI: 0.93, 1.63) for hyperlipidemia, RR = 1.06 (95% CI: 0.69, 1.61) for hypertension, and RR = 1.08 (95% CI: 0.88, 1.33) for the composite cohort].

conclusionsWe found no evidence that patient-reported healthcare discrimination was associated with less medication intensification. While not associated with this technical aspect of care, discrimination could still be associated with other aspects of care (e.g., patient-centeredness, communication).

Indexed as

Electronic PrescribingHealth PersonnelPrejudiceAdultAgedCaliforniaData CollectionDiabetes MellitusElectronic Health RecordsEthnicityFemaleHumansMaleMiddle AgedPatient SatisfactionQuality of Health Care

Identifiers

PMID21547610
PMCPMC3181298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.